| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Ornidazole | Ornidazole Epoxide Impurity | VE006265 | View CAS 16773-52-7 |
Ornidazole Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Ornidazole | Ornidazole Epoxide Impurity | VE006265 | View CAS 16773-52-7 |
| Catalogue No. | VE006265 |
| CAS No. | 16773-52-7 |
| Molecular Formula | C7H9N3O3 |
| Molecular Weight | 183.16 |
| Parent drug | Ornidazole |
| IUPAC Name | 2-Methyl-5-nitro-1-(oxiran-2-ylmethyl)-1H-imidazole |
| Synonyms | N/A |
| References | Sci-Hub, Oseltamivir compounding in the hospital pharmacy during the (H1N1) influenza pandemic, 10.1590/s1807-59322010001100004. (2021). Zidianzhan.net. https://sci-hub.zidianzhan.net/10.1590/s1807-59322010001100004 ? |
| Status | In-stock |
| ListName | Ornidazole Epoxide Impurity |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
